Novateor Research Laboratories Ltd (NOVATEOR)

Loading page…

Novateor Research Laboratories Ltd (NOVATEOR) · mywealthgrid

About

Novateor Research Laboratories Ltd operates in Personal Care within the Consumer Staples sector.

Face value: ₹10

Market cap

₹23 Cr

P/E

228.8×

P/B

—

Dividend yield

ROE

—

ROCE

—

Debt / equity

—

OPM

-2.4%

EPS (TTM)

₹0.2

Book value

—

52-week high

—

52-week low

—

540 historical price candles were omitted because the exchange source has not been verified.

Only one verified price point is available. The trend chart will appear when more exchange closes are stored.

Quick read

rule-based

Pros

No positive flags triggered.

Cons

−Expensive at 228.8× trailing earnings

Research score

Structured signal from quality, growth, valuation and momentum.

2/100

Business quality: 5
Valuation: 0

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore

₹ Cr	Mar 2024	Mar 2025	Mar 2026
	1	3	4
COGS	1	2	3
Gross profit	0	1	1
	1	1	1
Operating profit (EBITDA)	-0	-0	-0
OPM %	-27.3%	-4.7%	-2.4%
Depreciation	0	0	0
Interest	0	0	0
	0	0	0
Profit before tax	0	0	0
Tax	0	0	0
Tax %	40%	27.3%	9.1%
	0	0	0
PAT margin %	2.5%	2.9%	2.6%
EPS (₹)	0.1	0.2	0.2
Annual report	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2024	Mar 2025	Mar 2026
Equity capital	—	—	—
Reserves	—	—	—
Borrowings	—	—	—
	10	13	14
Total equity & liabilities	10	13	14
Fixed assets	—	3	3
CWIP	—	—	—
Investments	0	0	0
	10	9	11
Total assets	10	13	14

₹ Cr	Mar 2024	Mar 2025	Mar 2026
	-0	-1	-0
	-1	-0	-1
	1	1	1
Net cash flow	-0	0	0
Free cash flow	-1	-2	-0
CFO / Operating profit %	—	—	—

Compounded sales growth

7 years: —
5 years: —
3 years: —
1 year: 38%

Compounded profit growth

7 years: —
5 years: —
3 years: —
1 year: 25%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	21.5%	33.1%	34.2%
EBITDA margin %	-27.3%	-4.7%	-2.4%
EBIT margin %	-33.9%	-10.4%	-7.3%
PAT margin %	2.5%	2.9%	2.6%
Working capital
Receivable days	—	—	—
Inventory days	269	151	152
Payable days	—	—	—
NWC days	—	—	—
Leverage
Current ratio	6.27	5.61	4.58
Debt to EBITDA	—	—	—
Debt to equity	—	—	—
Interest coverage	2.7	2.7	2.3
Asset turnover	0.12	0.22	0.27
Return ratios
Return on assets %	0.3%	0.6%	0.7%
Return on capital employed %	0.9%	1.9%	1.8%
Return on equity %	—	—	—

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2024	Mar 2025	Sep 2025	Mar 2026
	60.87%	60.87%	50.9%	50.75%
FII	0%	0%	0%	0%
DII	0%	0%	0%	0%
Government	0%	0%	0%	0%
	39.13%	39.13%	49.1%	49.25%
No. of shareholders	160	142	172	172

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Novateor Research Laboratories Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

No events on record

Corporate actions, results dates and filings will appear here once ingested.

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

14 announcementsExport CSV

1 Oct 2026, 2:22 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

30 Sept 2026, 9:03 pmInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

29 Sept 2026, 9:21 pmCompany Update

Announcement under Regulation 30 (LODR)-Change in Registered Office Address

Change in Registered Office Address PDF

29 Sept 2026, 9:14 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

AGM PDF

5 Sept 2026, 10:23 pmOthers

Reg. 34 (1) Annual Report.

Reg. 34 (1) Annual Report PDF

5 Sept 2026, 10:13 pmAGM/EGM

Notice Of 15Th Annual General Meeting Of The Company

AGM PDF

3 Sept 2026, 9:34 pmCorp. Action

The Cut Off Date To Determine Eligible Shareholders Who Can Attend The 15Th Annual General Meeting Of The Company

Record Date PDF

3 Sept 2026, 9:24 pmAGM/EGM

15Th Annual General Meeting Of The Company

AGM PDF

Date	Category	Subject	Filing
1 Oct 2026, 2:22 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report	PDF
30 Sept 2026, 9:03 pm	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window

Loading announcements…

Ratio	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	21.5%	33.1%	34.2%
EBITDA margin %	-27.3%	-4.7%	-2.4%
EBIT margin %	-33.9%	-10.4%	-7.3%
PAT margin %	2.5%	2.9%	2.6%
Working capital
Receivable days	—	—	—
Inventory days	269	151	152
Payable days	—	—	—
NWC days	—	—	—
Leverage
Current ratio	6.27	5.61	4.58
Debt to EBITDA	—	—	—
Debt to equity	—	—	—
Interest coverage	2.7	2.7	2.3
Asset turnover	0.12	0.22	0.27
Return ratios
Return on assets %	0.3%	0.6%	0.7%
Return on capital employed %	0.9%	1.9%	1.8%
Return on equity %	—	—	—

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Godrej Consumer Products LimitedGODREJCPGODREJCP	₹85,949 Cr	₹90,085 Cr	₹16,050 Cr	₹3,257 Cr	20.8%	₹2,052 Cr	12.3%	23.9%	15.1%	12
Colgate Palmolive (India) LimitedCOLPALCOLPAL	₹47,192 Cr	₹47,192 Cr	₹6,204 Cr	₹1,900 Cr	31%	₹1,348 Cr	22%	106.4%	81.6%	-188
Cupid LimitedCUPIDCUPID	₹42,022 Cr	₹42,073 Cr	₹453 Cr	₹160 Cr	32.6%	₹137 Cr	30.3%	35.4%	27.3%	200
Gillette India LimitedGILLETTEGILLETTE	₹22,491 Cr	₹22,491 Cr	₹3,176 Cr	₹961 Cr	30.3%	₹668 Cr	21%	—	—	—
Procter & Gamble Hygiene And Health Care LimitedPGHHPGHH	₹21,577 Cr	₹21,577 Cr	₹4,245 Cr	₹1,075 Cr	25.3%	₹791 Cr	18.6%	—	—	—
Emami LimitedEMAMILTDEMAMILTD	₹16,266 Cr	₹16,389 Cr	₹3,915 Cr	₹976 Cr	25.5%	₹748 Cr	20.5%	30.3%	27.6%	8
Honasa Consumer LimitedHONASAHONASA	₹13,950 Cr	₹13,950 Cr	₹2,553 Cr	₹301 Cr	9.9%	₹249 Cr	8.4%	19.5%	15.4%	-78
Bajaj Consumer Care LimitedBAJAJCONBAJAJCON	₹6,516 Cr	₹6,516 Cr	₹1,240 Cr	₹264 Cr	19%	₹223 Cr	16.3%	30.5%	25.3%	42
Recode Studios LtdRECODERECODE	₹477 Cr	—	₹80 Cr	₹17 Cr	20.7%	₹11 Cr	14%	—	—	—
Radix Industries (India) LtdRADIXINDRADIXIND	₹193 Cr	₹193 Cr	₹48 Cr	₹4 Cr	7.6%	₹3 Cr	6.3%	19.6%	14.5%	65
H. R. Hygiene Products LtdHRHYGIENEHRHYGIENE	₹143 Cr	—	—	—	—	—	—	—	—	—
Jhs Svendgaard Laboratories LimitedJHSJHS	₹102 Cr	₹117 Cr	₹109 Cr	₹3 Cr	2.6%	₹-2 Cr	-1.9%	-0.8%	-1.1%	45

Novateor Research Laboratories Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Ratios

Ratio timeline

Shareholding

Quarterly record

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

No events on record

Announcements

Ratio timeline

Not in the F&O segment

No events on record

No fund holdings on record

Quarterly record

Board and management

Announcements

Annual reports

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth